What the FDA labels say about taking them together
Prednisolone and radium ra 223 dichloride
Radium ra 223 dichloride's FDA label of March 2, 2026 names prednisolone in its warnings and precautions section; the prednisolone labels PlainMeds reads (4) do not name radium ra 223 dichloride. The radium ra 223 dichloride label: “Increased Fractures and Mortality in Combination with Abiraterone plus Prednisone/Prednisolone:”
Check it at the source: the prednisolone FDA label on DailyMed (effective June 25, 2026, PAI Holdings, LLC dba PAI Pharma); the radium ra 223 dichloride FDA label on DailyMed (effective March 2, 2026, Bayer HealthCare Pharmaceuticals Inc.).
What does the prednisolone label say about radium ra 223 dichloride?
Prednisolone's label (effective June 25, 2026) and its 3 other brand-application labels do not name radium ra 223 dichloride in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (PrednisoLONE Sodium Phosphate), PAI Holdings, LLC dba PAI Pharma, effective June 25, 2026 (SPL set d1f937e7-fed5-4079-bd52-5d930b34ae9f), via openFDA; the full label on DailyMed
What does the radium ra 223 dichloride label say about prednisolone?
Radium ra 223 dichloride label, warnings and precautionsIncreased Fractures and Mortality in Combination with Abiraterone plus Prednisone/Prednisolone:
Source: FDA drug label (Xofigo), Bayer HealthCare Pharmaceuticals Inc., effective March 2, 2026 (SPL set a398400e-bd31-41a9-9696-4f7c06569ede), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Prednisolone | Radium ra 223 dichloride | |
|---|---|---|
| Labeled for | Anemia, Leukemia, lymphoma and myeloma, Multiple sclerosis, Osteoarthritis, Asthma, Allergies, Herpes and shingles, Crohn's disease and ulcerative colitis, Eczema (atopic dermatitis), Organ transplant rejection | Prostate cancer |
| Boxed warning | No | No |
| Pharmacy cost (NADAC) | $4.72 per mL 1% eye drop | n/a |
| Shortage now | No current entry | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once